OMI Owens & Minor Dashboard

Risks

• We face competition and accelerating pricing pressure.
• Our operating income is dependent on certain significant domestic suppliers.
• An inability to obtain key components, raw materials or manufactured products from third parties may have a material adverse effect on our Global Products segment.
• Our results of operations may suffer upon the bankruptcy, insolvency, or other credit failure of a customer that has a substantial amount owed to us.
• Changing conditions in the United States healthcare industry may impact our results of operations.
• We may not be able to refinance, extend or repay our substantial indebtedness which would have a material adverse affect on our financial condition.
• Our variable rate indebtedness subjects us to interest rate risk, which could cause our indebtedness service obligations to increase significantly.
• Our credit facilities and our existing notes have restrictive covenants that could limit our financial flexibility.
• We may incur product liability losses, litigation liability, product recalls, safety alerts or regulatory action associated with the products that we source, assemble, manufacture and sell which can be costly and disruptive to our business.
• We must obtain clearance or approval from the appropriate regulatory authorities prior to introducing a new product or a modification to an existing product. The regulatory clearance process may result in substantial costs, delays and limitations on the types and uses of products we can bring to market, any of which could have a material adverse effect on our business.
• Our business may be adversely affected if we are unable to adequately establish, maintain, protect and enforce our intellectual property and proprietary rights or prevent third parties from making unauthorized use of such rights.
• We may become subject to litigation brought by third parties claiming infringement, misappropriation or other violation by us of their intellectual property rights.
• Our business and operations depend on the proper functioning of critical facilities, supply chain and distribution networks.
• We are subject to stringent regulatory and licensing requirements.
• Compliance with the terms and conditions of Byram’s Corporate Integrity Agreement requires significant resources and, if we fail to comply, we could be subject to penalties or excluded from participation in government healthcare programs, which could seriously harm our results of operations, liquidity and financial condition.
• General economic conditions may adversely affect demand for our products and services.
• Our continued success is substantially dependent on positive perceptions of our reputation.
• Our inability to adequately integrate acquisitions could have a material adverse effect on our operations.
• Our ability to attract and retain talented and qualified teammates is critical to our success and competitiveness.